REGULATORY STRATEGY FOR REGISTRATION OF COMBINATION PRODUCTS TO US-FDA
Journal Title: International Journal of Drug Regulatory Affairs - Year 2014, Vol 2, Issue 3
Abstract
In pharmaceutical industry all the healthcare products are categorized into Drugs, Devices, and biologics and they are regulated by their respective departments of the regulatory authorities. Due to more and more development of science and technology in the current scenario, had led to the invention of innovative novel products in healthcare system for better diagnosis and treatment of diseases, advancement of these novel technologies have led to a the blurring of historical lines of separation between the healthcare products, so these advances had led to the existence of combination products. Combination products raise a variety of regulatory and review challenges compared with single-entity products. They have the potential to provide enhanced therapeutic advantages. It ranges in complexity from Drug-eluting stents to gene therapy systems and from chemotherapeutic Drugs combined with monoclonal antibodies to novel nanotechnology-based Drug delivery systems. They include innovative products for diagnostic and therapeutic treatments of cardiovascular, metabolic, and oncologic disorders, among other types of products. In this article we describe the regulations for registration of combination products in US and their regulatory considerations for identification, jurisdiction and review, premarket activities, applicability of Good Manufacturing Practices (GMPs) and post marketed requirements, adverse event reporting, inspection and enforcement.
Authors and Affiliations
Kotha Vihar, Elphine Prabahar, Rama Rao Nadendla, Desu Bhrama Srinivasarao
Keywords
Related Articles
- EP ID EP349828
- DOI 10.22270/ijdra.v2i3.139
- Views 81
- Downloads 0
Current Regulatory requirements for Registration of Nutraceuticals in India and USA
There is growing recognition of the potential role for nutraceuticals and dietary supplements in helping to reduce health risks and improve health quality. Pharmaceutical and nutritional companies are aware of the moneta...
ANALYTICAL METHOD DEVELOPMENT AND VALIDATION FOR THE ESTIMATION OF DILTIAZEM HYDROCHLORIDE IN BULK AND PHARMACEUTICAL DOSAGE FORM BY RP- HPLC
A simple, specific, precise and accurate Reverse Phase High Performance Liquid Chromatography (RP-HPLC) method was developed and validated for the estimation of Diltiazem Hydrochloride in bulk and pharmaceutical dosage f...
EFFECTS OF PH, SALT, TEMPERATURE ON CONVENTIONAL LIPOSOMES SIZE ENLARGEMENT ANALYZED BY OPTICAL MICROSCOPE
The objective of the present study was to investigate the effects of experimental conditions like pH, salt, temperature on the interactions of conventional liposomes. The model drug Stavudine was entrapped in the liposom...
REGULATIONS GOVERNING CLINICAL TRIALS IN INDIA, EUROPE AND USA COMPARATIVE STUDY
Clinical trials are research studies that explore whether a medical strategy, treatment, or device is safe and effective for humans. These studies also may show which medical approaches work best for certain illnesses or...
LYOPHILIZATION - PROCESS AND OPTIMIZATION FOR PHARMACEUTICALS
In this 21st century, Lyophilization emerges to be a novel trend for the drying of pharmaceuticals and biological that are thermolabile or are unstable in aqueous form but stable for longer periods in their dried form. T...